Paul Shelton is the US Director of Clinical Development. He joined P&F to help lead the introduction of P&F into the US and Canadian markets.
Paul has over 20 years of experience in the cardiology market, serving multiple sales and leadership positions managing multi-million dollar businesses for companies from Johnson & Johnson/Cordis, Boston Scientific, ev3, SentreHEART, and Atricure. He has experience bringing breakthrough technologies from early clinical research all the way through to full-scale commercialization. Paul’s passion is to provide innovative solutions to providers to help patients with unmet needs.
He graduated from Francis Marion University School of Business and completed a preceptorship at Tufts Medical School focused on Cardiology and Immunology.
